P2.04-02 AVANZAR: Phase III Study of Datopotamab Deruxtecan (Dato-DXd) + Durvalumab + Carboplatin as 1L Treatment of Advanced/mNSCLC

Saved in:
Bibliographic Details
Published in:Journal of thoracic oncology 2023-11, Vol.18 (11), p.S305-S306
Main Authors: Aggarwal, C., Cheema, P., Arrieta, O., Bonanno, L., Borghaei, H., Hu, Y., Kim, D.-W., de Castro Junior, G., Hepner, A., Deng, C., González del Riego, M., Kato, T.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1556-0864
DOI:10.1016/j.jtho.2023.09.525